Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 5,335	$ 15,034
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	2,552	2,051
Share based compensation	4,987	3,040
Deferred income taxes	(471)	(19)
Bad debt expense	292	104
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:
Accounts receivable	(324)	1,216
Inventories - finished goods	10,053	6,780
Prepaid income taxes	(927)	(911)
Prepaid expenses and other current assets	(771)	1,287
Accounts payable	(3,183)	(17,613)
Accrued expenses and other current liabilities	536	(1,188)
Net cash provided by operating activities	18,079	9,781
Cash flows from investing activities:
Purchase of minority interest investment in Vetster	(5,000)	0
Purchases of property and equipment	(3,329)	(1,266)
Net cash used in investing activities	(8,329)	(1,266)
Cash flows from financing activities:
Dividends paid	(18,402)	(18,322)
Net cash used in financing activities	(18,402)	(18,322)
Net decrease in cash and cash equivalents	(8,652)	(9,807)
Cash and cash equivalents, at beginning of period	111,080	118,718
Cash and cash equivalents, at end of period	102,428	108,911
Supplemental disclosure of cash flow information:
Cash paid for income taxes	3,870	5,580
Dividends payable in accrued expenses	$ 1,079	$ 329